Related Experiment Video
Updated: Apr 14, 2026
08:00
Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
Published on: May 26, 2021
14.7K
[Rapamycin decreases irradiation-induced hematopoietic system damage]
Zhen Wang1, Lin Song1, Han Zhang1
1Cyrus Tang Hematology Center, Soochow University, Suzhou 215123,China.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|April 29, 2015
Summary
Rapamycin pretreatment protected mice from irradiation-induced hematopoietic damage. It maintained bone marrow cells and promoted peripheral blood cell recovery, safeguarding spleen stem/progenitor cells.
Area of Science:
- Hematology
- Radiation Biology
- Immunology
Background:
- Irradiation causes significant damage to the hematopoietic system.
- Rapamycin is an immunosuppressant drug with potential cytoprotective effects.
Purpose of the Study:
- To investigate the protective role of rapamycin against irradiation-induced hematopoietic system damage.
- To evaluate the impact of rapamycin on peripheral blood cell counts and bone marrow cellularity post-irradiation.
Main Methods:
- Mice received rapamycin (4 mg/kg) or vehicle, followed by 5 Gy total body irradiation (TBI).
- Peripheral blood was analyzed for complete blood counts at various time points.
- Bone marrow cellularity and spleen colony-forming units (CFU-S) were assessed post-TBI.
Main Results:
- Rapamycin treatment maintained bone marrow nucleated cells and increased spleen CFU-S post-irradiation.
- While initial white blood cell and lymphocyte counts decreased similarly in both groups, rapamycin-treated mice showed faster restoration.
- Red blood cell and hemoglobin levels were better preserved in rapamycin-treated mice.
Conclusions:
- Rapamycin administration before irradiation offers significant protection against hematopoietic damage.
- It preserves bone marrow cellularity, aids peripheral blood cell recovery, and protects hematopoietic stem/progenitor cells in the spleen.
